Biopharmaceuticals Market to Reach USD 113,300 Million by 2026 at CAGR 4.7% – Valuates Reports

The Biopharmaceuticals Market is Segmented by Type (Monoclonal Antibodies, Interferon, Colony-Stimulating Factor, Erythropoietin , Insulin, Vaccines, Growth Hormones, Others), by Application (Tumor, Diabetes, Cardiovascular, Hemophilia, Others). The report covers global opportunity analysis

Read More

Glenmark’s Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of

Read More